Austin Littrell is associate editor of Medical Economics.
More than half of U.S. adults say AI will improve health outcomes and reduce costs, and three-quarters believe AI should play a role in health care education, survey says.
A new survey shows 11% of patients do not plan to get vaccinated, 54% are concerned about vaccine access—but 89% trust health care providers for vaccine information.
The potential CMS model would set a $2 copayment for common generic drugs in an effort to improve medication adherence.
Global data demonstrates optimism, regional disparities and knowledge gaps that need to be addressed to increased public acceptance of emerging technologies.
Peter H. Reilly, North American health care practice leader and chief sales officer at HUB International, joins the show to discuss risks that medical practices face in the year ahead.
Despite the proven effectiveness of cardiac rehabilitation services, high out-of-pocket costs may prevent patients from participating in the programs.
A machine learning tool designed to analyze vocal patterns for signs of depression successfully identified depression in 71% of patients who had it.
The administration announced three new telehealth rules, making permanent some temporary pandemic-era flexibilities and establishing new patient protections.
Rochelle P. Walensky, MD, MPH, former CDC director, co-authored a special report on the physician shortage in the U.S., published in the New England Journal of Medicine.
A new West Health-Gallup survey found that nearly half of Americans believe the country is headed in the wrong direction regarding health care costs.
The collaboration enables eligible customers to find and enroll in health benefits directly through Amazon.
A new report in Annals of Family Medicine urges AI developers to target time-saving AI solutions—and warns against overpromising.
A new study estimates that Americans are twice as likely to be diagnosed with dementia than previously believed.
Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, discusses the Trump administration's likely approach to health care.
Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, talks about how the Trump administration is more experienced this time around.
A record 26 physician-clients launched practices last year, according to a report from Specialdocs Consultants.
New perspective calls for regulatory reforms to address the rising trend of physician strikes in the U.S. based on international examples.
Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, advises primary care physicians on how to best navigate potential health care shifts under the Trump administration.
Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, talks about significant long-term implications of the Trump administration's approach to health care policy.
Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, explains how the Trump administration could work together, or clash, with Congress on health care legislation during their next term.
A Weill Cornell Medicine study found that one-third of all Medicare Part D pharmacy spending and nearly 40% of specialty drug spending within Medicare Part D was through pharmacies owned by the four largest PBMs: CVS, UnitedHealth Group, Cigna and Humana.
A Press Ganey report identified key gaps and areas for improvement based on member and patient experience data.
Sheila P. Burke, chair, Government Relations and Public Policy Group, Baker Donelson Law Firm, explains how the Trump administration might approach drug pricing policy.
